Diabetes Metab J.  2021 Jan;45(1):55-66. 10.4093/dmj.2019.0189.

Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study

• Ko YM
• Ko SH
• Han K
• Park YM
• Choi JY
• Kim SY
• Song SH
• Kim CH
• Kim SK

• KMID: 2514074
• DOI: http://doi.org/10.4093/dmj.2019.0189

Abstract

Influenza is a global public health problem causing considerable morbidity and mortality. Although vaccination is the most effective way to prevent infection, vaccination coverage is insufficient in people with chronic disease under 65 years, especially diabetes. The purpose of this study was to evaluate influenza vaccination coverage and identify factors associated with influenza vaccination in Korean diabetic adults under 65 years.

Data were obtained from 24,821 subjects in the Korea National Health and Nutrition Examination Survey (2014 to 2017). Socioeconomic, health-related, and diabetic factors were investigated for their relations with influenza vaccination in diabetic patients under 65 years using univariate and multivariate analyses.

Among 24,821 subjects, 1,185 were diabetic patients under 65 years and their influenza vaccination rate was 36.5%. Socioeconomic (older age, female gender, non-smoker, light alcohol drinker, lower educational level, and employed status), health-related factors (lower fasting glucose and glycosylated hemoglobin level, good self-perceived health status, more comorbidities, recent health screening, more outpatient visits, and diet therapy), and diabetic factors (more awareness and getting treated) were associated with influenza vaccination. In multivariate analysis, more awareness and getting treated for diabetes were associated with influenza vaccination in diabetic patients under 65 years (odds ratio, 1.496 and 1.413; 95% confidence interval, 1.022 to 2.188 and 1.018 to 2.054, respectively).

Influenza vaccination rate was low in diabetic patients under 65 years, especially in those with unawareness and not getting treated for diabetes. Active screening and treatment for diabetes may be helpful to improve the influenza vaccination rate in these patients.

Keyword

Awareness; Diabetes mellitus; Influenza, human; Therapeutics; Vaccination

Figure

• 

  Fig. 1 Influenza vaccination coverage rate by age groups in diabetic and non-diabetic groups.

Reference

1. World Health Organization: Diabetes 2018. cited 2020 May 22. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes/.

2. World Health Organization: Global report on diabetes 2016. cited 2020 May 22. Available from: https://www.who.int/diabetes/global-report/en/.

3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321:405–412.

4. Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006; 152:27–38.

5. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360:129–139.

6. Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, et al. Mortality from infectious diseases in diabetes. Nutr Metab Cardiovasc Dis. 2018; 28:444–450.

7. Ma CM, Yin FZ. The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: infection in type 2 diabetes. Medicine (Baltimore). 2019; 98:e16025.

8. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012; 16 Suppl 1:S27–S36.

9. Abu-Ashour W, Twells LK, Valcour JE, Gamble JM. Diabetes and the occurrence of infection in primary care: a matched cohort study. BMC Infect Dis. 2018; 18:67.

10. World Health Organization: Influenza (seasonal) 2018. cited 2020 May 22. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)/.

11. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012; 12:36–44.

12. Looijmans-Van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care. 2006; 29:1771–1776.

13. Dos Santos G, Tahrat H, Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: a systematic review. Hum Vaccin Immunother. 2018; 14:1853–1866.

14. Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer WEP, et al. Benefits of flu vaccination for persons with diabetes mellitus: a review. Vaccine. 2017; 35:5095–5101.

15. American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42:Suppl 1. S34–S45.

16. Centers for Disease Control and Prevention: about flu 2018. cited 2020 May 22. Available from: https://www.cdc.gov/flu/about/index.html.

17. World Health Organization: Prevention and control of influenza pandemics and annual epidemics 2003. cited 2020 May 22. Available from: https://apps.who.int/iris/handle/10665/78320.

18. Organization for Economic Cooperation and Development: influenza vaccination rates 2018. cited 2020 May 22. Available from: https://data.oecd.org/healthcare/influenza-vaccination-rates.htm#indicator-chart.

19. Seo J, Lim J. Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: effect of public health policies on vaccination behavior. Vaccine. 2018; 36:3666–3673.

20. O'Halloran AC, Lu PJ, Williams WW, Bridges CB, Singleton JA. Influenza vaccination coverage among people with high-risk conditions in the U.S. Am J Prev Med. 2016; 50:e15–e26.

21. Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Lopez de Andres A, Perez N, de Miguel AG. Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006. J Infect. 2008; 57:472–480.

22. Korea Centers for Disease Control & Prevention: Korea National Health & Nutrition Examination Survey 2017. cited 2020 May 22. Available from: https://knhanes.cdc.go.kr/knhanes/eng/index.do.

23. Kim BY, Won JC, Lee JH, Kim HS, Park JH, Ha KH, et al. Diabetes fact sheets in Korea, 2018: an appraisal of current status. Diabetes Metab J. 2019; 43:487–494.

24. Korean Diabetes Association: Diabetes fact sheet in Korea 2019. cited 2020 May 22. Available from: https://www.diabetes.or.kr/bbs/index.html?code=e_resource&mode=tlist.

25. Shin HY, Chung JH, Hwang HJ, Kim TH. Factors influencing on influenza vaccination and its trends of coverage in patients with diabetes in Korea: a population-based cross-sectional study. Vaccine. 2018; 36:91–97.

26. UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res. 1990; 13:1–11.

27. Siitonen O, Uusitupa M, Pyorala K, Voutilainen E, Lansimies E. Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics. Acta Med Scand. 1986; 220:205–212.

28. Cusick M, Meleth AD, Agron E, Fisher MR, Reed GF, Knatterud GL, et al. Early Treatment Diabetc Retinopathy Study Research Group. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care. 2005; 28:617–625.

29. Athamneh LN, Sansgiry SS. Influenza vaccination in patients with diabetes: disparities in prevalence between African Americans and Whites. Pharm Pract (Granada). 2014; 12:410.

30. Cha SH, Paik JH, Lee MR, Yang H, Park SG, Jeon YJ, et al. Influenza vaccination coverage rate according to the pulmonary function of Korean adults aged 40 years and over: analysis of the fifth Korean National Health and Nutrition Examination Survey. J Korean Med Sci. 2016; 31:709–714.

31. Choi KH, Park SM, Lee K, Lee JH, Park JS. Influenza vaccination and associated factors among Korean cancer survivors: a cross-sectional analysis of the fourth & fifth Korea National Health and Nutrition Examination Surveys. J Korean Med Sci. 2014; 29:1061–1068.

32. Oh MG, Han MA, Yun NR, Park J, Ryu SY, Kim DM, et al. A population-based, nationwide cross-sectional study on influenza vaccination status among cancer survivors in Korea. Int J Environ Res Public Health. 2015; 12:10133–10149.

33. Chung JH, Kim TH, Han CH. Factors influencing influenza vaccination among South Korean adult asthma patients: a nationwide population-based cross-sectional study. J Asthma. 2018; 55:294–299.

34. Shin HY, Park S, Park SM. Gaps in health behaviours and use of preventive services between patients with diabetes and the general population: a population-based cross-sectional study. BMJ Open. 2018; 8:e017937.

35. Yu MC, Chou YL, Lee PL, Yang YC, Chen KT. Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan. Hum Vaccin Immunother. 2014; 10:1028–1035.

36. Deeks A, Lombard C, Michelmore J, Teede H. The effects of gender and age on health related behaviors. BMC Public Health. 2009; 9:213.

37. Dorner TE, Rasky E, Stein KV, Stronegger WJ, Kautzky-Willer A, Rieder A. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men. Wien Med Wochenschr. 2011; 161:136–142.

38. Verger P, Cortaredona S, Pulcini C, Casanova L, Peretti-Watel P, Launay O. Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France. Clin Microbiol Infect. 2015; 21:930.

39. Jimenez-Garcia R, Jimenez I, Garrido PC, Hernandez-Barrera V, de Andres AL, del Barrio JL, et al. Coverage and predictors of influenza vaccination among adults with diabetes in Spain. Diabetes Res Clin Pract. 2008; 79:510–517.

40. De Perio MA, Wiegand DM, Evans SM. Low influenza vaccination rates among child care workers in the United States: assessing knowledge, attitudes, and behaviors. J Community Health. 2012; 37:272–281.

41. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine. 2009; 27:4018–4024.

42. Takayama M, Wetmore CM, Mokdad AH. Characteristics associated with the uptake of influenza vaccination among adults in the United States. Prev Med. 2012; 54:358–362.

43. Rodriguez-Rieiro C, Dominguez-Berjon MF, Esteban-Vasallodominguez-Berjon MD, Cuadrado AR, Carrasco-Garrido P, Jimenez-Garcia R. Coverage and predictors of influenza vaccine uptake among adults aged 16 to 59 years suffering from a chronic condition in Madrid, Spain. Hum Vaccin. 2011; 7:557–562.

44. Wu S, Yang P, Li H, Ma C, Zhang Y, Wang Q. Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study. BMC Public Health. 2013; 13:636.

45. Lee KC, Han K, Kim JY, Nam GE, Han BD, Shin KE, et al. Socioeconomic status and other related factors of seasonal influenza vaccination in the South Korean adult population based on a nationwide cross-sectional study. PLoS One. 2015; 10:e0117305.

46. Ryu SY, Kim SH, Park HS, Park J. Influenza vaccination among adults 65 years or older: a 2009-2010 community health survey in the Honam region of Korea. Int J Environ Res Public Health. 2011; 8:4197–4206.

47. Yang HJ, Cho SI. Influenza vaccination coverage among adults in Korea: 2008-2009 to 2011-2012 seasons. Int J Environ Res Public Health. 2014; 11:12162–12173.